Overview

A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese Participants

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the pharmacokinetics (explores what the body does to the drug) and safety of darunavir, and will be administered in combination with Ritonavir in healthy adult Japanese male participants.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen Pharmaceutical K.K.

Treatments:

Darunavir
Ritonavir